Michael Detke
2019
In 2019, Michael Detke earned a total compensation of $1.1M as Chief Medical Officer at Cortexyme, a 360% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $106,625 |
|---|---|
| Option Awards | $620,466 |
| Salary | $373,077 |
| Total | $1,100,168 |
Detke received $620.5K in option awards, accounting for 56% of the total pay in 2019.
Detke also received $106.6K in non-equity incentive plan and $373.1K in salary.
Rankings
In 2019, Michael Detke's compensation ranked 8,838th out of 13,971 executives tracked by ExecPay. In other words, Detke earned more than 36.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,838 out of 13,971 | 37th |
Division Manufacturing | 3,524 out of 5,701 | 38th |
Major group Chemicals And Allied Products | 1,333 out of 2,200 | 39th |
Industry group Drugs | 1,135 out of 1,886 | 40th |
Industry Biological Products, Except Diagnostic Substances | 254 out of 389 | 35th |
Source: SEC filing on April 22, 2020.
Detke's colleagues
We found four more compensation records of executives who worked with Michael Detke at Cortexyme in 2019.